articleTop 1% cited

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

Journal of Clinical Oncology · 2001 · Vol. 19(16) · pp. 3622–3634

Charles M. Balch✉(Johns Hopkins University)Seng‐Jaw Soong(Johns Hopkins University)Jeffrey E. Gershenwald(Johns Hopkins University)John F. Thompson(Johns Hopkins University)Douglas S. Reintgen(Johns Hopkins University)Natale Cascinelli(Johns Hopkins University)Marshall M. Urist(Johns Hopkins University)Kelly M. McMasters(Johns Hopkins University)Merrick I. Ross(Johns Hopkins University)John M. Kirkwood(Johns Hopkins University)Michael B. Atkins(Johns Hopkins University)John A. Thompson(Johns Hopkins University)Daniel G. Coit(Johns Hopkins University)David R. Byrd(Johns Hopkins University)Renée A. Desmond(Johns Hopkins University)Yuting Zhang(Johns Hopkins University)Ping‐Yu Liu(Johns Hopkins University)Gary H. Lyman(Johns Hopkins University)Aberto Morabito(Johns Hopkins University)

View via DOI Publisher page

Abstract

The results of this evidence-based methodology were incorporated into the AJCC melanoma staging as described in the companion publication.

Cutaneous Melanoma Detection and Management Advanced Biosensing Techniques and Applications Melanoma and MAPK PathwaysMedicineMelanomaOccultCancerProportional hazards modelStage (stratigraphy)Cancer stagingInternal medicineSurvival analysisOncology

MeSH terms

AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanomaMiddle AgedNeoplasm MetastasisNeoplasm StagingPredictive Value of TestsSkin Neoplasms

Citations

2,391

FWCI

36.75

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma